
HealthMore in Health→
40Hz Sensory Stimulation Shows Benefits for Mild Alzheimer’s
Key Takeaways
- The 663-person HOPE trial included mild and moderate Alzheimer’s subgroups.
- The mild subgroup showed statistically significant slowing of decline on three reported measures.
- The overall study missed its primary endpoint, and the moderate subgroup showed no clinical benefit.
- Cognito says it will seek FDA approval for its 40Hz Spectris device in mild Alzheimer’s.
DE
DT Editorial Team··via medicalxpress.com

















